These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 33934405)

  • 1. Invasive aspergillosis in solid organ transplantation: Diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study).
    Gioia F; Filigheddu E; Corbella L; Fernández-Ruiz M; López-Medrano F; Pérez-Ayala A; Aguado JM; Fariñas MC; Arnaiz F; Calvo J; Cifrian JM; Gonzalez-Rico C; Vidal E; Torre-Cisneros J; Ras MM; Pérez S; Sabe N; López-Soria LM; Rodríguez-Alvarez RJ; Montejo JM; Valerio M; Machado M; Muñoz P; Linares L; Bodro M; Moreno A; Fernández-Cruz A; Cantón R; Moreno S; Martin-Davila P; Fortún J
    Mycoses; 2021 Nov; 64(11):1334-1345. PubMed ID: 33934405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study.
    Neofytos D; Chatzis O; Nasioudis D; Boely Janke E; Doco Lecompte T; Garzoni C; Berger C; Cussini A; Boggian K; Khanna N; Manuel O; Mueller NJ; van Delden C;
    Transpl Infect Dis; 2018 Aug; 20(4):e12898. PubMed ID: 29668068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive Aspergillosis in solid-organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
    Husain S; Camargo JF
    Clin Transplant; 2019 Sep; 33(9):e13544. PubMed ID: 30900296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology, clinical characteristics, and outcome of invasive aspergillosis in renal transplant patients.
    Hoyo I; Sanclemente G; de la Bellacasa JP; Cofán F; Ricart MJ; Cardona M; Colmenero J; Fernández J; Escorsell A; Navasa M; Moreno A; Cervera C
    Transpl Infect Dis; 2014 Dec; 16(6):951-7. PubMed ID: 25318640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants.
    Minari A; Husni R; Avery RK; Longworth DL; DeCamp M; Bertin M; Schilz R; Smedira N; Haug MT; Mehta A; Gordon SM
    Transpl Infect Dis; 2002 Dec; 4(4):195-200. PubMed ID: 12535262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outbreak of invasive aspergillosis in heart transplant recipients: The role of screening computed tomography scans in asymptomatic patients and universal antifungal prophylaxis.
    Kabbani D; Goldraich L; Ross H; Rotstein C; Husain S
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29125713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies.
    Dib RW; Hachem RY; Chaftari AM; Ghaly F; Jiang Y; Raad I
    BMC Infect Dis; 2018 Dec; 18(1):656. PubMed ID: 30545320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid.
    Pasqualotto AC; Xavier MO; Sánchez LB; de Oliveira Costa CD; Schio SM; Camargo SM; Camargo JJ; Sukiennik TC; Severo LC
    Transplantation; 2010 Aug; 90(3):306-11. PubMed ID: 20548265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical risk factors for invasive aspergillosis in lung transplant recipients: Results of an international cohort study.
    Aguilar CA; Hamandi B; Fegbeutel C; Silveira FP; Verschuuren EA; Ussetti P; Chin-Hong PV; Sole A; Holmes-Liew C; Billaud EM; Grossi PA; Manuel O; Levine DJ; Barbers RG; Hadjiliadis D; Singer LG; Husain S
    J Heart Lung Transplant; 2018 Oct; 37(10):1226-1234. PubMed ID: 30139546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases Group.
    Herbrecht R; Patterson TF; Slavin MA; Marchetti O; Maertens J; Johnson EM; Schlamm HT; Donnelly JP; Pappas PG
    Clin Infect Dis; 2015 Mar; 60(5):713-20. PubMed ID: 25414266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of serum and bronchoalveolar lavage galactomannan in diagnosing invasive aspergillosis in solid-organ transplant recipients.
    Tabarsi P; Soraghi A; Marjani M; Zandian P; Baghaei P; Najafizadeh K; Droudinia A; Sarrafzadeh SA; Javanmard P; Mansouri D
    Exp Clin Transplant; 2012 Jun; 10(3):278-81. PubMed ID: 22631066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on invasive aspergillosis using galactomannan enzyme immunoassay and determining antifungal drug susceptibility among hospitalized patients with hematologic malignancies or candidates for organ transplantation.
    Ardi P; Daie-Ghazvini R; Hashemi SJ; Salehi MR; Bakhshi H; Rafat Z; Zareei M; Getso M; Basiri S; Sarwestani HK; Boroujeini ZB; Ahmadikia K
    Microb Pathog; 2020 Oct; 147():104382. PubMed ID: 32663605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response.
    Neofytos D; Garcia-Vidal C; Lamoth F; Lichtenstern C; Perrella A; Vehreschild JJ
    BMC Infect Dis; 2021 Mar; 21(1):296. PubMed ID: 33761875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there still a place for serum galactomannan in the diagnosis of invasive aspergillosis in children at high risk and under antifungal prophylaxis?
    Gerard R; Gabriel F; Accoceberry I; Imbert S; Ducassou S; Angoso M; Jubert C
    Mycoses; 2024 Jul; 67(7):e13764. PubMed ID: 38970226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies.
    Raad II; Zakhem AE; Helou GE; Jiang Y; Kontoyiannis DP; Hachem R
    Int J Antimicrob Agents; 2015 Mar; 45(3):283-8. PubMed ID: 25455847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive aspergillosis in kidney transplant recipients: a cohort study.
    Pérez-Sáez MJ; Mir M; Montero MM; Crespo M; Montero N; Gómez J; Horcajada JP; Pascual J
    Exp Clin Transplant; 2014 Apr; 12(2):101-5. PubMed ID: 24702140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive aspergillosis in patients with severe alcoholic hepatitis.
    Gustot T; Maillart E; Bocci M; Surin R; Trépo E; Degré D; Lucidi V; Taccone FS; Delforge ML; Vincent JL; Donckier V; Jacobs F; Moreno C
    J Hepatol; 2014 Feb; 60(2):267-74. PubMed ID: 24055548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric Invasive Aspergillosis: a Retrospective Review of 59 Cases.
    Özen S; Özdemir H; Taşkin EÇ; Arga G; Konca HK; Çakmakli HF; Haskoloğlu Ş; Okulu E; Dinçaslan H; İnce E; İleri T; Taçyildiz N; Doğu F; Evren E; Us E; Karahan ZC; Fitöz S; Kendirli T; Kuloğlu Z; Tutar E; İkincioğullari A; Ünal E; Ertem M; İnce E; Çiftçi E
    Jpn J Infect Dis; 2023 Mar; 76(2):113-119. PubMed ID: 36450573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive pulmonary aspergillosis in solid-organ transplant patients in the intensive care unit.
    Klein J; Rello J; Dimopoulos G; Bulpa P; Blot K; Vogelaers D; Blot S
    Transpl Infect Dis; 2022 Feb; 24(1):e13746. PubMed ID: 34843161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing incidence of invasive aspergillosis in pediatric hematology oncology patients over the last decade: a retrospective single centre study.
    Rubio PM; Sevilla J; González-Vicent M; Lassaletta A; Cuenca-Estrella M; Díaz MA; Riesco S; Madero L
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):642-6. PubMed ID: 19684521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.